Fuse Medical, Inc.
FZMD
$0.0899
-$0.01-10.01%
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 5.00M | 3.98M | 4.89M | 4.54M | 4.67M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.00M | 3.98M | 4.89M | 4.54M | 4.67M |
| Cost of Revenue | 1.53M | 1.17M | 2.27M | 1.48M | 2.03M |
| Gross Profit | 3.47M | 2.82M | 2.61M | 3.05M | 2.64M |
| SG&A Expenses | 3.07M | 2.95M | 3.19M | 2.93M | 2.89M |
| Depreciation & Amortization | 32.70K | 33.40K | -88.80K | 82.20K | 34.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.63M | 4.15M | 5.37M | 4.49M | 4.95M |
| Operating Income | 368.90K | -165.60K | -487.90K | 44.90K | -281.20K |
| Income Before Tax | 314.80K | -222.80K | 3.57M | -2.10K | -317.80K |
| Income Tax Expenses | 7.20K | 5.60K | 6.40K | 7.30K | 5.20K |
| Earnings from Continuing Operations | 307.60K | -228.40K | 3.56M | -9.40K | -322.90K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 307.60K | -228.40K | 3.56M | -9.40K | -322.90K |
| EBIT | 368.90K | -165.60K | -487.90K | 44.90K | -281.20K |
| EBITDA | 401.60K | -132.20K | -453.50K | 127.10K | -246.80K |
| EPS Basic | 0.00 | 0.00 | 0.05 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.04 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 70.32M | 70.32M | 70.32M | 70.32M | 70.32M |
| Average Diluted Shares Outstanding | 78.03M | 70.32M | 100.48M | 70.32M | 70.32M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
